191 related articles for article (PubMed ID: 16855454)
1. Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment.
Vaishnavi S; Gadde K; Alamy S; Zhang W; Connor K; Davidson JR
J Clin Psychopharmacol; 2006 Aug; 26(4):373-8. PubMed ID: 16855454
[TBL] [Abstract][Full Text] [Related]
2. Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study.
Lundt L
J Affect Disord; 2004 Aug; 81(2):173-8. PubMed ID: 15306145
[TBL] [Abstract][Full Text] [Related]
3. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
[TBL] [Abstract][Full Text] [Related]
6. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ
Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016
[TBL] [Abstract][Full Text] [Related]
7. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
[TBL] [Abstract][Full Text] [Related]
8. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
[TBL] [Abstract][Full Text] [Related]
9. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
10. Modafinil for excessive sleepiness associated with shift-work sleep disorder.
Czeisler CA; Walsh JK; Roth T; Hughes RJ; Wright KP; Kingsbury L; Arora S; Schwartz JR; Niebler GE; Dinges DF;
N Engl J Med; 2005 Aug; 353(5):476-86. PubMed ID: 16079371
[TBL] [Abstract][Full Text] [Related]
11. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
Boellner SW; Earl CQ; Arora S
Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
[TBL] [Abstract][Full Text] [Related]
12. Modafinil: a second look. Confirmed efficacy in narcolepsy.
Prescrire Int; 1999 Feb; 8(39):5-7. PubMed ID: 10557564
[TBL] [Abstract][Full Text] [Related]
13. Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study.
Dunlop BW; Crits-Christoph P; Evans DL; Hirschowitz J; Solvason HB; Rickels K; Garlow SJ; Gallop RJ; Ninan PT
J Clin Psychopharmacol; 2007 Dec; 27(6):614-9. PubMed ID: 18004129
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S
Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364
[TBL] [Abstract][Full Text] [Related]
15. Modafinil: new indication. For a minority of patients with sleep apnoea.
Prescrire Int; 2007 Jun; 16(89):102-3. PubMed ID: 17582924
[TBL] [Abstract][Full Text] [Related]
16. A prospective trial of modafinil as an adjunctive treatment of major depression.
DeBattista C; Lembke A; Solvason HB; Ghebremichael R; Poirier J
J Clin Psychopharmacol; 2004 Feb; 24(1):87-90. PubMed ID: 14709953
[TBL] [Abstract][Full Text] [Related]
17. Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92).
Rasmussen NA; Schrøder P; Olsen LR; Brødsgaard M; Undén M; Bech P
Nord J Psychiatry; 2005; 59(3):173-8. PubMed ID: 16208839
[TBL] [Abstract][Full Text] [Related]
18. Modafinil therapy for apathy in an elderly patient.
Padala PR; Burke WJ; Bhatia SC
Ann Pharmacother; 2007 Feb; 41(2):346-9. PubMed ID: 17264158
[TBL] [Abstract][Full Text] [Related]
19. A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy.
Price CS; Taylor FB
Depress Anxiety; 2005; 21(4):149-53. PubMed ID: 16035049
[TBL] [Abstract][Full Text] [Related]
20. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants.
Lam JY; Freeman MK; Cates ME
Ann Pharmacother; 2007 Jun; 41(6):1005-12. PubMed ID: 17519297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
